Global Regenerative Medicine Market to Reach $30.8 Billion by 2030

ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Regenerative Medicine Industry" - https://www.reportlinker.com/p05443567/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Regenerative Medicine Market to Reach $30.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Regenerative Medicine estimated at US$9.6 Billion in the year 2022, is projected to reach a revised size of US$30.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030. Cell Therapy, one of the segments analyzed in the report, is projected to record a 16.3% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Gene Therapy segment is readjusted to a revised 15.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 14.7% CAGR

The Regenerative Medicine market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.4% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Select Competitors (Total 52 Featured)
- AlloSource
- Anika Therapeutics, Inc.
- Bioventus LLC
- DePuy Synthes Spine, Inc.
- Exactech, Inc.
- Integra LifeSciences Holdings Corp.
- LifeNet Health, Inc.
- Medtronic, PLC
- NovaBone Products LLC
- NuVasive, Inc.
- Orthofix International N.V.
- Osiris Therapeutics, Inc.
- Smith & Nephew plc
- Stryker Corporation
- Wright Medical Technology, Inc.
- Zimmer Biomet Holdings, Inc.


Read the full report: https://www.reportlinker.com/p05443567/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Regenerative Medicine: A Preface
Recent Market Activity
An Overview of Regenerative Medicine in Bone and Joint
Applications
Current and Future Analysis
Developed Markets Dominate, Developing to Drive Growth
Regenerative Medicine - Past, Present & Future
Another Revolution in the Making?
Conventional Chemical Medicine Vs Regenerative Medicine
Regenerative Medicine - Bypassing the Ethical Concerns
Regenerative Medicine Throws Up Several New Therapies
Current Global Market for Regenerative Medicine
Market Potential
Therapeutic Companies and Products in Regenerative Medicine -
Current Status
Regenerative Medicine - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
AlloSource (US)
Anika Therapeutics, Inc. (US)
Bioventus LLC (US)
DePuy Synthes Companies (US)
DePuy Synthes Spine, Inc. (US)
Exactech, Inc. (US)
Integra LifeSciences Holdings Corp. (US)
LifeNet Health, Inc. (US)
Medtronic, plc (Ireland)
NovaBone Products LLC (US)
NuVasive, Inc. (US)
Orthofix International N.V. (Netherlands)
Osiris Therapeutics, Inc. (US)
Smith & Nephew plc (UK)
Stryker Corporation (US)
Wright Medical Technology, Inc. (US)
Zimmer Biomet Holdings, Inc. (US)

3. MARKET TRENDS & DRIVERS
A Combination of Factors to Drive Regenerative Medicine Market
Burgeoning Global Population Offers Significant Growth
Opportunities
Aging Global Population: Need for New Effective Treatments
Increasing Healthcare Spending in Emerging Markets:
Opportunities in Store
Government Support and Increased Private Sector Participation
Investment and Funding Landscape
Major M&A Activity and Strategic Alliances in Regenerative
Medicine: 2011-2016
Recent Advancements in the Science of Regenerative Medicine
Advanced Ceramics Gaining Preeminence in Regenerative Medicine
Field
3D Organ & Tissue Printing: Still in Early Stages
Nanotechnology in Regenerative Medicine
Issues to be Sorted Out
Need for New Scientific and Technological Standards
Standardized Guidelines
Clinical Translation - Collaboration of Multidisciplinary
Skills is Essential
The Question of Apt Business Models - The Service and Product
Approach
Autologous or Service Approach Preferred by European Firms
Allogenic or Product Approach - Slow to Develop
Regenerative Medicine Requires Improved Biomaterials
Investors Wary of Funding Regenerative Medicine
Regenerative Medicine Field Lags Behind Due to Segregated Focus
Challenges Encountered by Regenerative Medicine
Scientific and Technological Challenges
Barriers in Sharing Intellectual Property Rights
Viable Manufacturing Technologies and Skilled Personnel Crucial
Strict Regulations Push up Operational Costs
Challenges Facing Autologous Cell Therapies

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Regenerative Medicine by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 2: World Historic Review for Regenerative Medicine by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for Regenerative Medicine by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for Cell
Therapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 5: World Historic Review for Cell Therapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Cell Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for Gene
Therapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 8: World Historic Review for Gene Therapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Gene Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Tissue Engineering by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 11: World Historic Review for Tissue Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 12: World 16-Year Perspective for Tissue Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Other Product Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Other Product Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Other Product Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Biologically Derived by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Biologically Derived by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Biologically Derived by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Synthetic by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 20: World Historic Review for Synthetic by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Synthetic by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Genetically Engineered by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 23: World Historic Review for Genetically Engineered by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Genetically Engineered
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Other Material Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 26: World Historic Review for Other Material Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 27: World 16-Year Perspective for Other Material Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Musculoskeletal by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 29: World Historic Review for Musculoskeletal by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 30: World 16-Year Perspective for Musculoskeletal by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for
Oncology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 32: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 33: World 16-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for
Cardiovascular by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 35: World Historic Review for Cardiovascular by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 36: World 16-Year Perspective for Cardiovascular by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 37: World Recent Past, Current & Future Analysis for
Dermatology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 38: World Historic Review for Dermatology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 39: World 16-Year Perspective for Dermatology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 40: World Recent Past, Current & Future Analysis for
Ophthalmology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 41: World Historic Review for Ophthalmology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR

Table 42: World 16-Year Perspective for Ophthalmology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 43: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 44: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 45: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 46: World Regenerative Medicine Market Analysis of Annual
Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Regenerative Medicine Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 47: USA Recent Past, Current & Future Analysis for
Regenerative Medicine by Product Type - Cell Therapy, Gene
Therapy, Tissue Engineering and Other Product Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 48: USA Historic Review for Regenerative Medicine by
Product Type - Cell Therapy, Gene Therapy, Tissue Engineering
and Other Product Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 49: USA 16-Year Perspective for Regenerative Medicine by
Product Type - Percentage Breakdown of Value Sales for Cell
Therapy, Gene Therapy, Tissue Engineering and Other Product
Types for the Years 2014, 2023 & 2030

Table 50: USA Recent Past, Current & Future Analysis for
Regenerative Medicine by Material Type - Biologically Derived,
Synthetic, Genetically Engineered and Other Material Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 51: USA Historic Review for Regenerative Medicine by
Material Type - Biologically Derived, Synthetic, Genetically
Engineered and Other Material Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 52: USA 16-Year Perspective for Regenerative Medicine by
Material Type - Percentage Breakdown of Value Sales for
Biologically Derived, Synthetic, Genetically Engineered and
Other Material Types for the Years 2014, 2023 & 2030

Table 53: USA Recent Past, Current & Future Analysis for
Regenerative Medicine by Application - Musculoskeletal,
Oncology, Cardiovascular, Dermatology, Ophthalmology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 54: USA Historic Review for Regenerative Medicine by
Application - Musculoskeletal, Oncology, Cardiovascular,
Dermatology, Ophthalmology and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 55: USA 16-Year Perspective for Regenerative Medicine by
Application - Percentage Breakdown of Value Sales for
Musculoskeletal, Oncology, Cardiovascular, Dermatology,
Ophthalmology and Other Applications for the Years 2014, 2023 &
2030

CANADA
Table 56: Canada Recent Past, Current & Future Analysis for
Regenerative Medicine by Product Type - Cell Therapy, Gene
Therapy, Tissue Engineering and Other Product Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 57: Canada Historic Review for Regenerative Medicine by
Product Type - Cell Therapy, Gene Therapy, Tissue Engineering
and Other Product Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 58: Canada 16-Year Perspective for Regenerative Medicine
by Product Type - Percentage Breakdown of Value Sales for Cell
Therapy, Gene Therapy, Tissue Engineering and Other Product
Types for the Years 2014, 2023 & 2030

Table 59: Canada Recent Past, Current & Future Analysis for
Regenerative Medicine by Material Type - Biologically Derived,
Synthetic, Genetically Engineered and Other Material Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 60: Canada Historic Review for Regenerative Medicine by
Material Type - Biologically Derived, Synthetic, Genetically
Engineered and Other Material Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 61: Canada 16-Year Perspective for Regenerative Medicine
by Material Type - Percentage Breakdown of Value Sales for
Biologically Derived, Synthetic, Genetically Engineered and
Other Material Types for the Years 2014, 2023 & 2030

Table 62: Canada Recent Past, Current & Future Analysis for
Regenerative Medicine by Application - Musculoskeletal,
Oncology, Cardiovascular, Dermatology, Ophthalmology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 63: Canada Historic Review for Regenerative Medicine by
Application - Musculoskeletal, Oncology, Cardiovascular,
Dermatology, Ophthalmology and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 64: Canada 16-Year Perspective for Regenerative Medicine
by Application - Percentage Breakdown of Value Sales for
Musculoskeletal, Oncology, Cardiovascular, Dermatology,
Ophthalmology and Other Applications for the Years 2014, 2023 &
2030

JAPAN
Regenerative Medicine Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 65: Japan Recent Past, Current & Future Analysis for
Regenerative Medicine by Product Type - Cell Therapy, Gene
Therapy, Tissue Engineering and Other Product Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 66: Japan Historic Review for Regenerative Medicine by
Product Type - Cell Therapy, Gene Therapy, Tissue Engineering
and Other Product Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 67: Japan 16-Year Perspective for Regenerative Medicine
by Product Type - Percentage Breakdown of Value Sales for Cell
Therapy, Gene Therapy, Tissue Engineering and Other Product
Types for the Years 2014, 2023 & 2030

Table 68: Japan Recent Past, Current & Future Analysis for
Regenerative Medicine by Material Type - Biologically Derived,
Synthetic, Genetically Engineered and Other Material Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 69: Japan Historic Review for Regenerative Medicine by
Material Type - Biologically Derived, Synthetic, Genetically
Engineered and Other Material Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 70: Japan 16-Year Perspective for Regenerative Medicine
by Material Type - Percentage Breakdown of Value Sales for
Biologically Derived, Synthetic, Genetically Engineered and
Other Material Types for the Years 2014, 2023 & 2030

Table 71: Japan Recent Past, Current & Future Analysis for
Regenerative Medicine by Application - Musculoskeletal,
Oncology, Cardiovascular, Dermatology, Ophthalmology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 72: Japan Historic Review for Regenerative Medicine by
Application - Musculoskeletal, Oncology, Cardiovascular,
Dermatology, Ophthalmology and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 73: Japan 16-Year Perspective for Regenerative Medicine
by Application - Percentage Breakdown of Value Sales for
Musculoskeletal, Oncology, Cardiovascular, Dermatology,
Ophthalmology and Other Applications for the Years 2014, 2023 &
2030

CHINA
Regenerative Medicine Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 74: China Recent Past, Current & Future Analysis for
Regenerative Medicine by Product Type - Cell Therapy, Gene
Therapy, Tissue Engineering and Other Product Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 75: China Historic Review for Regenerative Medicine by
Product Type - Cell Therapy, Gene Therapy, Tissue Engineering
and Other Product Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 76: China 16-Year Perspective for Regenerative Medicine
by Product Type - Percentage Breakdown of Value Sales for Cell
Therapy, Gene Therapy, Tissue Engineering and Other Product
Types for the Years 2014, 2023 & 2030

Table 77: China Recent Past, Current & Future Analysis for
Regenerative Medicine by Material Type - Biologically Derived,
Synthetic, Genetically Engineered and Other Material Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 78: China Historic Review for Regenerative Medicine by
Material Type - Biologically Derived, Synthetic, Genetically
Engineered and Other Material Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 79: China 16-Year Perspective for Regenerative Medicine
by Material Type - Percentage Breakdown of Value Sales for
Biologically Derived, Synthetic, Genetically Engineered and
Other Material Types for the Years 2014, 2023 & 2030

Table 80: China Recent Past, Current & Future Analysis for
Regenerative Medicine by Application - Musculoskeletal,
Oncology, Cardiovascular, Dermatology, Ophthalmology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 81: China Historic Review for Regenerative Medicine by
Application - Musculoskeletal, Oncology, Cardiovascular,
Dermatology, Ophthalmology and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 82: China 16-Year Perspective for Regenerative Medicine
by Application - Percentage Breakdown of Value Sales for
Musculoskeletal, Oncology, Cardiovascular, Dermatology,
Ophthalmology and Other Applications for the Years 2014, 2023 &
2030

EUROPE
Regenerative Medicine Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 83: Europe Recent Past, Current & Future Analysis for
Regenerative Medicine by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR

Table 84: Europe Historic Review for Regenerative Medicine by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 85: Europe 16-Year Perspective for Regenerative Medicine
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2014, 2023 & 2030

Table 86: Europe Recent Past, Current & Future Analysis for
Regenerative Medicine by Product Type - Cell Therapy, Gene
Therapy, Tissue Engineering and Other Product Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 87: Europe Historic Review for Regenerative Medicine by
Product Type - Cell Therapy, Gene Therapy, Tissue Engineering
and Other Product Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 88: Europe 16-Year Perspective for Regenerative Medicine
by Product Type - Percentage Breakdown of Value Sales for Cell
Therapy, Gene Therapy, Tissue Engineering and Other Product
Types for the Years 2014, 2023 & 2030

Table 89: Europe Recent Past, Current & Future Analysis for
Regenerative Medicine by Material Type - Biologically Derived,
Synthetic, Genetically Engineered and Other Material Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 90: Europe Historic Review for Regenerative Medicine by
Material Type - Biologically Derived, Synthetic, Genetically
Engineered and Other Material Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 91: Europe 16-Year Perspective for Regenerative Medicine
by Material Type - Percentage Breakdown of Value Sales for
Biologically Derived, Synthetic, Genetically Engineered and
Other Material Types for the Years 2014, 2023 & 2030

Table 92: Europe Recent Past, Current & Future Analysis for
Regenerative Medicine by Application - Musculoskeletal,
Oncology, Cardiovascular, Dermatology, Ophthalmology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 93: Europe Historic Review for Regenerative Medicine by
Application - Musculoskeletal, Oncology, Cardiovascular,
Dermatology, Ophthalmology and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 94: Europe 16-Year Perspective for Regenerative Medicine
by Application - Percentage Breakdown of Value Sales for
Musculoskeletal, Oncology, Cardiovascular, Dermatology,
Ophthalmology and Other Applications for the Years 2014, 2023 &
2030

FRANCE
Regenerative Medicine Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 95: France Recent Past, Current & Future Analysis for
Regenerative Medicine by Product Type - Cell Therapy, Gene
Therapy, Tissue Engineering and Other Product Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 96: France Historic Review for Regenerative Medicine by
Product Type - Cell Therapy, Gene Therapy, Tissue Engineering
and Other Product Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 97: France 16-Year Perspective for Regenerative Medicine
by Product Type - Percentage Breakdown of Value Sales for Cell
Therapy, Gene Therapy, Tissue Engineering and Other Product
Types for the Years 2014, 2023 & 2030

Table 98: France Recent Past, Current & Future Analysis for
Regenerative Medicine by Material Type - Biologically Derived,
Synthetic, Genetically Engineered and Other Material Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 99: France Historic Review for Regenerative Medicine by
Material Type - Biologically Derived, Synthetic, Genetically
Engineered and Other Material Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 100: France 16-Year Perspective for Regenerative Medicine
by Material Type - Percentage Breakdown of Value Sales for
Biologically Derived, Synthetic, Genetically Engineered and
Other Material Types for the Years 2014, 2023 & 2030

Table 101: France Recent Past, Current & Future Analysis for
Regenerative Medicine by Application - Musculoskeletal,
Oncology, Cardiovascular, Dermatology, Ophthalmology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 102: France Historic Review for Regenerative Medicine by
Application - Musculoskeletal, Oncology, Cardiovascular,
Dermatology, Ophthalmology and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 103: France 16-Year Perspective for Regenerative Medicine
by Application - Percentage Breakdown of Value Sales for
Musculoskeletal, Oncology, Cardiovascular, Dermatology,
Ophthalmology and Other Applications for the Years 2014, 2023 &
2030

GERMANY
Regenerative Medicine Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 104: Germany Recent Past, Current & Future Analysis for
Regenerative Medicine by Product Type - Cell Therapy, Gene
Therapy, Tissue Engineering and Other Product Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 105: Germany Historic Review for Regenerative Medicine by
Product Type - Cell Therapy, Gene Therapy, Tissue Engineering
and Other Product Types Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR

Table 106: Germany 16-Year Perspective for Regenerative
Medicine by Product Type - Percentage Breakdown of Value Sales
for Cell Therapy, Gene Therapy, Tissue Engineering and Other
Product Types for the Years 2014, 2023 & 2030

Table 107: Germany Recent Past, Current & Future Analysis for
Regenerative Medicine by Material Type - Biologically Derived,
Synthetic, Genetically Engineered and Other Material Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 108: Germany Historic Review for Regenerative Medicine by
Material Type - Biologically Derived, Synthetic, Genetically
Engineered and Other Material Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2014 through
2021 and % CAGR

Table 109: Germany 16-Year Perspective for Regenerative
Medicine by Material Type - Percentage Breakdown of Value Sales
for Biologically Derived, Synthetic, Genetically Engineered and
Other Material Types for the Years 2014, 2023 & 2030

Table 110: Germany Recent Past, Current & Future Analysis for
Regenerative Medicine by Application - Musculoskeletal,
Oncology, Cardiovascular, Dermatology, Ophthalmology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 111: Germany Historic Review for Regenerative Medicine by
Application - Musculoskeletal, Oncology, Cardiovascular,
Dermatology, Ophthalmology and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 112: Germany 16-Year Perspective for Regenerative
Medicine by Application - Percentage Breakdown of Value Sales
for Musculoskeletal, Oncology, Cardiovascular, Dermatology,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05443567/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001